System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Salvatore Oliva is an expert in Gastroenterology at IRCCS San Raffaele Pisana (Italy). As of October 2026, ScienceLeadR ranks Salvatore Oliva in the top 1% of experts worldwide for Esophagitis, Eosinophilia and Gastroenteritis. Salvatore Oliva has authored 344 publications, the most recent in 2026, and is an investigator in 29 clinical trials, 14 of them ongoing. SLR score: 1,464 (community average: 125). How the SLR is computed.

LeadR Profile

Salvatore Oliva IRCCS San Raffaele Pisana Italy
1 464 ScienceLeadR Reputation 1464

Unlock

Register Login
Network Map

Gastroenterology

Subspecialties: Pediatrics - Nutrition - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2008 - 2026
Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 344

Citations

Citations: 6 196 1st author: 54 Last author: 41 Unique author: 2

Main journals

Dig Liver Dis 92
J Pediatr Gastroenterol Nutr 34
Gastroenterology 30
Gastrointest Endosc 18
J Crohns Colitis 15

Best Journals

Gastroenterology 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Dupilumab improves clinical outcome assessments in children with eosinophilic esophagitis in a randomized phase 3 study.
PMID 42928144 — esophagitis, eosinophilic esophagitis, caregivers, signs and symptoms, outcome assessment, health care, gastrointestinal diseases, child		BMC Gastroenterol20260
Long-Term Effectiveness of Dupilumab in Eosinophilic Esophagitis: Results From the DUPEOETALY Study.
PMID 42036094 — esophagitis, eosinophilic esophagitis, eosinophils, therapeutics, child		Clin Gastroenterol Hepatol20260
Association Between Early Bedside Clinical Findings and Need for Organ Support or Mortality in Critically Ill Children: A Multicenter Study.
PMID 42897758 — mortality, emergencies, triage, emergency medicine, intensive care units, pediatric, critical illness, intensive care units, emergency service, hospital, child		Pediatr Emerg Care20260
Improving Endoscopic Scoring Accuracy in Pediatric Inflammatory Bowel Disease: Impact of a Focused Training Intervention.
PMID 42846258 — endoscopy, inflammatory bowel diseases, colitis, ulcerative, child		Endosc Int Open20260
The PREFERENDO Delphi consensus: Minimum quality standards and core reporting elements for pediatric gastrointestinal endoscopy.
PMID 42731961 — endoscopy, gastrointestinal, endoscopy		Dig Liver Dis20260

Clinical Studies 29

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

Phase 3 18
N/A 5
Phase 4 4
Phase 2 2

By status:

Completed 14
Recruiting 14
Unknown 1

By type:

Interventional 28
Observational 1

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 2
multicentric5to9 1
multicentricup10 19

Main Topics

Ongoing Clinical Trials

14 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Efficacy Safety and Pharmacokinetics of Guselkumab in Pediatric Participants with Moderately to Severely Active Crohn s Disease
2023-504735-41-00 — interleukin-23, safety, crohn disease, pharmacokinetics		Phase 3Recruiting2024
A study to test how well PLENVU a bowel cleansing medicine works in children and teenagers before they have a colonoscopy exam
2025-522046-42-00 — safety, colonic diseases, colonoscopy, child		Phase 3Recruiting2026
A Long term Extension Study of Guselkumab in Pediatric Participants
2023-509560-16-00 — arthritis, psoriatic, colitis, safety, crohn disease, arthritis, colitis, ulcerative		Phase 3Recruiting2024
Efficacy and Safety of Vedolizumab Intravenous in Pediatric Chronic Pouchitis
2023-504773-20-00 — pouchitis, safety, maintenance, therapeutics, pharmacokinetics		Phase 3Recruiting2024
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
2024-511458-32-00 — colitis, safety, maintenance, colitis, ulcerative, child, pharmacokinetics		Phase 3Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS